Aydin-Kose F - Search Results

1

Probiotic kefir consumption improves serum apolipoprotein A1 levels in metabolic syndrome patients: a randomized controlled clinical trial.

Bellikci-Koyu E, Sarer-Yurekli BP, Karagozlu C, Aydin-Kose F, Ozgen AG, Buyuktuncer Z. Bellikci-Koyu E, et al. Among authors: aydin kose f. Nutr Res. 2022 Jun;102:59-70. doi: 10.1016/j.nutres.2022.02.006. Epub 2022 Mar 7. Nutr Res. 2022. PMID: 35405603 Clinical Trial.

2

Effects of Regular Kefir Consumption on Gut Microbiota in Patients with Metabolic Syndrome: A Parallel-Group, Randomized, Controlled Study.

Bellikci-Koyu E, Sarer-Yurekli BP, Akyon Y, Aydin-Kose F, Karagozlu C, Ozgen AG, Brinkmann A, Nitsche A, Ergunay K, Yilmaz E, Buyuktuncer Z. Bellikci-Koyu E, et al. Among authors: aydin kose f. Nutrients. 2019 Sep 4;11(9):2089. doi: 10.3390/nu11092089. Nutrients. 2019. PMID: 31487797 Free PMC article. Clinical Trial.

3

Propolis loaded liposomes: evaluation of antimicrobial and antioxidant activities.

Aytekin AA, Tuncay Tanrıverdi S, Aydın Köse F, Kart D, Eroğlu İ, Özer Ö. Aytekin AA, et al. Among authors: aydin kose f. J Liposome Res. 2020 Jun;30(2):107-116. doi: 10.1080/08982104.2019.1599012. Epub 2019 Jul 30. J Liposome Res. 2020. PMID: 30913939

4

Antioxidant properties evaluation of topical astaxanthin formulations as anti-aging products.

Eren B, Tuncay Tanrıverdi S, Aydın Köse F, Özer Ö. Eren B, et al. J Cosmet Dermatol. 2019 Feb;18(1):242-250. doi: 10.1111/jocd.12665. Epub 2018 May 10. J Cosmet Dermatol. 2019. PMID: 29745467

5

Synthesis, biological evaluation, and docking studies of some 5-chloro-2(3H)-benzoxazolone Mannich bases derivatives as cholinesterase inhibitors.

Uysal S, Parlar S, Tarikogullari AH, Aydin Kose F, Alptuzun V, Soyer Z. Uysal S, et al. Arch Pharm (Weinheim). 2018 Apr;351(3-4):e1700273. doi: 10.1002/ardp.201700273. Epub 2018 Mar 12. Arch Pharm (Weinheim). 2018. PMID: 29527733

6

Dexamethasone loaded PLGA nanoparticles for potential local treatment of oral precancerous lesions.

Rençber S, Aydın Köse F, Karavana SY. Rençber S, et al. Among authors: aydin kose f. Pharm Dev Technol. 2020 Feb;25(2):149-158. doi: 10.1080/10837450.2019.1673407. Epub 2019 Nov 22. Pharm Dev Technol. 2020. PMID: 31553253

7

Synthesis, biological evaluations and molecular modelling studies of novel indolin-2-ones designing as FGFR inhibitors.

Çoban G, Aydın Köse F. Çoban G, et al. Among authors: aydin kose f. Saudi Pharm J. 2019 Nov;27(7):952-967. doi: 10.1016/j.jsps.2019.07.004. Epub 2019 Jul 11. Saudi Pharm J. 2019. PMID: 31997902 Free PMC article.

8

Dual-Prevention for UV-Induced Skin Damage: Incorporation of Melatonin-Loaded Elastic Niosomes into Octyl Methoxycinnamate Pickering Emulsions.

Arslan Azizoglu G, Tuncay Tanriverdi S, Aydin Kose F, Ballar Kirmizibayrak P, Ozer O. Arslan Azizoglu G, et al. AAPS PharmSciTech. 2017 Nov;18(8):2987-2998. doi: 10.1208/s12249-017-0786-1. Epub 2017 May 10. AAPS PharmSciTech. 2017. PMID: 28493002

9

Production of wheat germ oil containing multilayer hydrogel dressing.

Türkoğlu GC, Sarıışık M, Karavana SY, Aydın Köse F. Türkoğlu GC, et al. Among authors: aydin kose f. Carbohydr Polym. 2021 Oct 1;269:118287. doi: 10.1016/j.carbpol.2021.118287. Epub 2021 Jun 2. Carbohydr Polym. 2021. PMID: 34294313

10

Design, syntheses, theoretical calculations, MM-GBSA, potential anti-cancer and enzyme activities of novel Schiff base compounds.

Yalazan H, Koç D, Aydın Kose F, Fandaklı S, Tüzün B, Akgül Mİ, Sadeghian N, Taslimi P, Kantekin H. Yalazan H, et al. Among authors: aydin kose f. J Biomol Struct Dyn. 2023 Nov 3:1-14. doi: 10.1080/07391102.2023.2274972. Online ahead of print. J Biomol Struct Dyn. 2023. PMID: 37921706

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

13 results

Search Page